Dose Reduction to the Swallowing Apparatus and the Salivary Glands by De-Intensification of Postoperative Radiotherapy in Patients with Head and Neck Cancer: First (Treatment Planning) Results of the Prospective Multicenter DIREKHT Trial
Abstract
:1. Background
2. Material and Methods
2.1. Target Volumes and Dose Prescriptions
2.2. Organs at Risk
2.3. Dose Limitations and Treatment Planning
2.4. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Contreras, J.A.; Spencer, C.; de Wees, T.; Haughey, B.; Henke, L.E.; Chin, R.I.; Paniello, R.; Rich, J.; Jackson, R.; Oppelt, P.; et al. Eliminating Postoperative Radiation to the Pathologically Node-Negative Neck: Long-Term Results of a Prospective Phase II Study. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2019. [Google Scholar] [CrossRef] [PubMed]
- Huang, S.H.; Waldron, J.; Bratman, S.V.; Su, J.; Kim, J.; Bayley, A.; Cho, J.; Giuliani, M.; Hope, A.; Ringash, J.; et al. Re-evaluation of Ipsilateral Radiation for T1-T2N0-N2b Tonsil Carcinoma at the Princess Margaret Hospital in the Human Papillomavirus Era, 25 Years Later. Int. J. Radiat. Oncol. Biol. Phys. 2017, 98, 159–169. [Google Scholar] [CrossRef] [PubMed]
- Wirtz, M.M.; Temming, S.; Kocher, M.; Kunze, S.; Semrau, R. Low risk of contralateral lymph node recurrence in lateralized head and neck carcinoma after postoperative ipsilateral radiotherapy. Strahlentherapie und Onkologie Organ der Deutschen Rontgengesellschaft 2019. [Google Scholar] [CrossRef] [PubMed]
- Cooper, J.S.; Pajak, T.F.; Forastiere, A.A.; Jacobs, J.; Campbell, B.H.; Saxman, S.B.; Kish, J.A.; Kim, H.E.; Cmelak, A.J.; Rotman, M.; et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 2004, 350, 1937–1944. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bernier, J.; Domenge, C.; Ozsahin, M.; Matuszewska, K.; Lefebvre, J.L.; Greiner, R.H.; Giralt, J.; Maingon, P.; Rolland, F.; Bolla, M.; et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N. Engl. J. Med. 2004, 350, 1945–1952. [Google Scholar] [CrossRef] [Green Version]
- Fietkau, R.; Lautenschläger, C.; Sauer, R.; Dunst, J.; Becker, A.; Wendt, M.B.; Grüschow, K.; Hess, C.; Budach, V.; Iro, H.; et al. Postoperative concurrent radiochemotherapy versus radiotherapy in high-risk SCCA of the head and neck: Results of the German phase III trial ARO 96–3. J. Clin. Oncol. 2006, 24, 5507. [Google Scholar] [CrossRef]
- Peters, L.J.; Goepfert, H.; Ang, K.K.; Byers, R.M.; Maor, M.H.; Guillamondegui, O.; Morrison, W.H.; Weber, R.S.; Garden, A.S.; Frankenthaler, R.A.; et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 1993, 26, 3–11. [Google Scholar] [CrossRef]
- Onbasi, Y.; Lettmaier, S.; Hecht, M.; Semrau, S.; Iro, H.; Kesting, M.; Fietkau, R.; Haderlein, M. Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? A monocentric retrospective analysis of a previously defined low-risk patient population treated with standard-of-care radiotherapy. Strahlentherapie und Onkologie Organ der Deutschen Rontgengesellschaft 2019. [Google Scholar] [CrossRef]
- Rathod, S.; Livergant, J.; Klein, J.; Witterick, I.; Ringash, J. A systematic review of quality of life in head and neck cancer treated with surgery with or without adjuvant treatment. Oral Oncol. 2015, 51, 888–900. [Google Scholar] [CrossRef]
- Oskam, I.M.; Verdonck-de Leeuw, I.M.; Aaronson, N.K.; Witte, B.I.; de Bree, R.; Doornaert, P.; Langendijk, J.A.; Leemans, C.R. Prospective evaluation of health-related quality of life in long-term oral and oropharyngeal cancer survivors and the perceived need for supportive care. Oral Oncol. 2013, 49, 443–448. [Google Scholar] [CrossRef]
- Mehanna, H.M.; Morton, R.P. Deterioration in quality-of-life of late (10-year) survivors of head and neck cancer. Clin. Otolaryngol. Off. J. Ent-Uk; Off. J. Neth. Soc. Oto-Rhino-Laryngol. Cervico-Facial Surg. 2006, 31, 204–211. [Google Scholar] [CrossRef] [PubMed]
- Bjordal, K.; de Graeff, A.; Fayers, P.M.; Hammerlid, E.; van Pottelsberghe, C.; Curran, D.; Ahlner-Elmqvist, M.; Maher, E.J.; Meyza, J.W.; Bredart, A.; et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur. J. Cancer 2000, 36, 1796–1807. [Google Scholar] [CrossRef] [PubMed]
- Mowry, S.E.; Ho, A.; Lotempio, M.M.; Sadeghi, A.; Blackwell, K.E.; Wang, M.B. Quality of life in advanced oropharyngeal carcinoma after chemoradiation versus surgery and radiation. Laryngoscope 2006, 116, 1589–1593. [Google Scholar] [CrossRef] [PubMed]
- Christianen, M.E.; Langendijk, J.A.; Westerlaan, H.E.; van de Water, T.A.; Bijl, H.P. Delineation of organs at risk involved in swallowing for radiotherapy treatment planning. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 2011, 101, 394–402. [Google Scholar] [CrossRef]
- Speer, S.; Klein, A.; Kober, L.; Weiss, A.; Yohannes, I.; Bert, C. Automation of radiation treatment planning: Evaluation of head and neck cancer patient plans created by the Pinnacle(3) scripting and Auto-Planning functions. Strahlentherapie und Onkologie Organ der Deutschen Rontgengesellschaft 2017, 193, 656–665. [Google Scholar] [CrossRef]
- Tribius, S.; Sommer, J.; Prosch, C.; Bajrovic, A.; Muenscher, A.; Blessmann, M.; Kruell, A.; Petersen, C.; Todorovic, M.; Tennstedt, P. Xerostomia after radiotherapy. What matters--mean total dose or dose to each parotid gland? Strahlentherapie und Onkologie Organ der Deutschen Rontgengesellschaft 2013, 189, 216–222. [Google Scholar] [CrossRef]
- Eisbruch, A.; Kim, H.M.; Feng, F.Y.; Lyden, T.H.; Haxer, M.J.; Feng, M.; Worden, F.P.; Bradford, C.R.; Prince, M.E.; Moyer, J.S.; et al. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: Swallowing organs late complication probabilities and dosimetric correlates. Int. J. Radiat. Oncol. Biol. Phys. 2011, 81, e93–e99. [Google Scholar] [CrossRef] [Green Version]
- Caudell, J.J.; Schaner, P.E.; Desmond, R.A.; Meredith, R.F.; Spencer, S.A.; Bonner, J.A. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 2010, 76, 403–409. [Google Scholar] [CrossRef]
- Teguh, D.N.; Levendag, P.C.; Noever, I.; van Rooij, P.; Voet, P.; van der Est, H.; Sipkema, D.; Sewnaik, A.; Baatenburg de Jong, R.J.; de la Bije, D.; et al. Treatment techniques and site considerations regarding dysphagia-related quality of life in cancer of the oropharynx and nasopharynx. Int. J. Radiat. Oncol. Biol. Phys. 2008, 72, 1119–1127. [Google Scholar] [CrossRef]
- Levendag, P.C.; Teguh, D.N.; Voet, P.; van der Est, H.; Noever, I.; de Kruijf, W.J.; Kolkman-Deurloo, I.K.; Prevost, J.B.; Poll, J.; Schmitz, P.I.; et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: A dose-effect relationship. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 2007, 85, 64–73. [Google Scholar] [CrossRef]
- Schwartz, D.L.; Hutcheson, K.; Barringer, D.; Tucker, S.L.; Kies, M.; Holsinger, F.C.; Ang, K.K.; Morrison, W.H.; Rosenthal, D.I.; Garden, A.S.; et al. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2010, 78, 1356–1365. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Deantonio, L.; Masini, L.; Brambilla, M.; Pia, F.; Krengli, M. Dysphagia after definitive radiotherapy for head and neck cancer. Correlation of dose-volume parameters of the pharyngeal constrictor muscles. Strahlentherapie und Onkologie Organ der Deutschen Rontgengesellschaft 2013, 189, 230–236. [Google Scholar] [CrossRef] [PubMed]
- Dirix, P.; Abbeel, S.; Vanstraelen, B.; Hermans, R.; Nuyts, S. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: Dose-effect relationships for the swallowing structures. Int. J. Radiat. Oncol. Biol. Phys. 2009, 75, 385–392. [Google Scholar] [CrossRef] [PubMed]
- Caglar, H.B.; Tishler, R.B.; Othus, M.; Burke, E.; Li, Y.; Goguen, L.; Wirth, L.J.; Haddad, R.I.; Norris, C.M.; Court, L.E.; et al. Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2008, 72, 1110–1118. [Google Scholar] [CrossRef]
- Li, B.; Li, D.; Lau, D.H.; Farwell, D.G.; Luu, Q.; Rocke, D.M.; Newman, K.; Courquin, J.; Purdy, J.A.; Chen, A.M. Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy. Radiat. Oncol. 2009, 4, 52. [Google Scholar] [CrossRef] [Green Version]
- Jensen, K.; Lambertsen, K.; Grau, C. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: Frequency, intensity and correlation with dose and volume parameters. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 2007, 85, 74–82. [Google Scholar] [CrossRef]
- Haderlein, M.; Semrau, S.; Ott, O.; Speer, S.; Bohr, C.; Fietkau, R. Dose-dependent deterioration of swallowing function after induction chemotherapy and definitive chemoradiotherapy for laryngopharyngeal cancer. Strahlentherapie und Onkologie Organ der Deutschen Rontgengesellschaft 2014, 190, 192–198. [Google Scholar] [CrossRef]
- Mortensen, H.R.; Jensen, K.; Aksglaede, K.; Behrens, M.; Grau, C. Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 2013, 107, 288–294. [Google Scholar] [CrossRef]
- Charters, E.K.; Bogaardt, H.; Freeman-Sanderson, A.L.; Ballard, K.J. Systematic review and meta-analysis of the impact of dosimetry to dysphagia and aspiration related structures. Head Neck 2019, 41, 1984–1998. [Google Scholar] [CrossRef]
- Nutting, C.M.; Morden, J.P.; Harrington, K.J.; Urbano, T.G.; Bhide, S.A.; Clark, C.; Miles, E.A.; Miah, A.B.; Newbold, K.; Tanay, M.; et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011, 12, 127–136. [Google Scholar] [CrossRef] [Green Version]
- Kam, M.K.; Leung, S.F.; Zee, B.; Chau, R.M.; Suen, J.J.; Mo, F.; Lai, M.; Ho, R.; Cheung, K.Y.; Yu, B.K.; et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2007, 25, 4873–4879. [Google Scholar] [CrossRef] [PubMed]
- Feng, F.Y.; Kim, H.M.; Lyden, T.H.; Haxer, M.J.; Worden, F.P.; Feng, M.; Moyer, J.S.; Prince, M.E.; Carey, T.E.; Wolf, G.T.; et al. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: Clinical and functional results. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2010, 28, 2732–2738. [Google Scholar] [CrossRef] [PubMed]
- Vainshtein, J.M.; Moon, D.H.; Feng, F.Y.; Chepeha, D.B.; Eisbruch, A.; Stenmark, M.H. Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirus-related oropharyngeal cancer. Int. J. Radiat. Oncol. Biol. Phys. 2015, 91, 925–933. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Petkar, I.; Rooney, K.; Roe, J.W.; Patterson, J.M.; Bernstein, D.; Tyler, J.M.; Emson, M.A.; Morden, J.P.; Mertens, K.; Miles, E.; et al. DARS: A phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer. BMC Cancer 2016, 16, 770. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gensheimer, M.F.; Nyflot, M.; Laramore, G.E.; Liao, J.J.; Parvathaneni, U. Contribution of submandibular gland and swallowing structure sparing to post-radiation therapy PEG dependence in oropharynx cancer patients treated with split-neck IMRT technique. Radiat. Oncol. 2016, 11, 151. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rodrigo, J.P.; Grilli, G.; Shah, J.P.; Medina, J.E.; Robbins, K.T.; Takes, R.P.; Hamoir, M.; Kowalski, L.P.; Suarez, C.; Lopez, F.; et al. Selective neck dissection in surgically treated head and neck squamous cell carcinoma patients with a clinically positive neck: Systematic review. Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol. 2018, 44, 395–403. [Google Scholar] [CrossRef] [PubMed]
- Tiong, A.; Lao, L.; MacKean, J.; Goonetilleke, M.; Kron, T. Faculty of Radiation Oncology Position Paper on the use of Image-Guided Radiation Therapy. J. Med. Imaging Radiat. Oncol. 2016, 60, 772–780. [Google Scholar] [CrossRef]
- Nutting, C.M. Intensity Modulated Radiotherapy (IMRT) in head and neck cancers—An overview. Gulf J. Oncol. 2012, 12, 17–26. [Google Scholar]
- Ursino, S.; D’Angelo, E.; Mazzola, R.; Merlotti, A.; Morganti, R.; Cristaudo, A.; Paiar, F.; Musio, D.; Alterio, D.; Bacigalupo, A.; et al. A comparison of swallowing dysfunction after three-dimensional conformal and intensity-modulated radiotherapy: A systematic review by the Italian Head and Neck Radiotherapy Study Group. Strahlentherapie und Onkologie Organ der Deutschen Rontgengesellschaft 2017, 193, 877–889. [Google Scholar] [CrossRef]
- van der Veen, J.; Nuyts, S. Can Intensity-Modulated-Radiotherapy Reduce Toxicity in Head and Neck Squamous Cell Carcinoma? Cancers 2017, 9, 135. [Google Scholar] [CrossRef] [Green Version]
- Mortensen, H.R.; Overgaard, J.; Jensen, K.; Specht, L.; Overgaard, M.; Johansen, J.; Evensen, J.F.; Andersen, E.; Andersen, L.J.; Hansen, H.S.; et al. Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer. Acta Oncol. 2013, 52, 1535–1542. [Google Scholar] [CrossRef] [PubMed]
Characteristics | No. of Patients | % | |
---|---|---|---|
Sex | |||
Male | 19 | 63.3 | |
Female | 11 | 36.7 | |
Age at diagnosis, y | |||
Median | 59 | ||
Range | 40–80 | ||
Primary tumor site | |||
Oral cavity | 9 | 30 | |
Oropharynx | 21 | 70 | |
Base of the tongue | 4 | ||
Tonsil | 16 | ||
Other | 1 | ||
pT classification | |||
T1 | 10 | 33.3 | |
T2 | 16 | 53.3 | |
T3 | 4 | 13.3 | |
pN classification | |||
N0 | 1 | 3.3 | |
N1 | 9 | 30 | |
N2a | 10 | 33.3 | |
N2b | 10 | 33.3 | |
Perinodal spread | |||
Yes | 6 | 20 | |
No | 24 | 80 | |
Lymphangiosis | |||
L0 | 25 | 83.3 | |
L1 | 5 | 16.7 | |
Hemangiosis | |||
V0 | 28 | 93.3 | |
V1 | 2 | 6.7 | |
Perineural spread | |||
Pn0 | 24 | 80 | |
Pn1 | 6 | 20 | |
Grading | |||
G1 | 0 | 0 | |
G2 | 9 | 30 | |
G3 | 21 | 70 | |
Tracheostomy | |||
yes | 5 | 16.7 | |
yes, temporary during surgery | 15 | 50 | |
no | 10 | 33.3 | |
HPV | |||
Positive | 9 | 30 | |
Negative | 16 | 53.3 | |
Not defined | 5 | 16.7 | |
Neck dissection | |||
Only ipsilateral | 13 | 43.3 | |
Bilateral | 17 | 56.7 | |
Total removed lymph nodes, n | |||
Median | 32 | ||
Range | 12–90 | ||
No. of affected lymph nodes, n | |||
Median | 1 | ||
Range | 0–3 | ||
Simultaneous Chemotherapy, n | |||
Yes | 15 | 50 | |
No | 15 | 50 |
Organs at Risk | DIREKHT Treatment Plan Mean Dose Applied (Gy) ± Standard Deviation | Standard Treatment Plan Mean Dose Applied (Gy) ± Standard Deviation | p Value | Median Difference Between Study-and Standard Treatment Plans (Gy) (Minimum; Maximum) |
---|---|---|---|---|
Superior constrictor muscle (SCM) | 53.8 ± 6.4 | 61.3 ± 2.0 | 0.000 | 6.9 (−0.7; 20.5) |
Middle constrictor muscle (MCM) | 47.2 ± 9.3 | 59.3 ± 3.0 | 0.000 | 13.1 (−0.7; 23.3) |
Inferior constrictor muscle (ICM) | 35.9 ± 9.5 | 53.6 ± 5.0 | 0.000 | 18.2 (2.3; 32.3) |
Constrictor muscles | 48.8 ± 6.6 | 59.4 ± 2.2 | 0.000 | 10.7 (2.2; 20.9) |
Musculus cricopharyngeus | 33.6 ± 8.6 | 48.7 ± 7.6 | 0.000 | 15.5 (0.9; 29.9) |
Esophagus inlet muscle (EIM) | 37.2 ± 11.1 | 45.5 ± 10.0 | 0.000 | 6.9 (-1.4; 26.5) |
SCM to EIM | 46.3 ± 6.4 | 57.2 ± 2.9 | 0.000 | 10.5 (2.7; 20.9) |
Cervical esophagus | 29.1 ± 8.9 | 33.5 ± 6.2 | 0.002 | 3.5 (−8.3; 19.7) |
Soft palate | 59.1 ± 5.1 | 62.0 ± 2.0 | 0.002 | 1.0 (-1.9; 13.9) |
Base of tongue | 55.6 ± 7.7 | 60.7 ± 2.3 | 0.000 | 3.8 (−2.1; 19.9) |
Oral cavity | 52.2 ± 8.5 | 57.1 ± 4.5 | 0.000 | 5.7 (−2.7; 16.2) |
Glottic larynx | 30.5 ± 11.4 | 49.4 ± 8.5 | 0.000 | 17.2 (1.5; 35.6) |
Supraglottic larynx | 41.7 ± 11.2 | 57.0 ± 4.2 | 0.000 | 16.4 (−0.2; 26.4) |
Arytenoid cartilages | 30.4 ± 10.9 | 50.1 ± 7.8 | 0.000 | 19.0 (2.3; 34.8) |
Ipsilateral parotid gland | 38.9 ± 7.7 | 40.1 ± 7.5 | 0.002 | 1.5 (−3.6; 3.9) |
Contralateral parotid gland | 7.4 ± 2.2 | 21.5 ± 2.8 | 0.000 | 15.1 (6.6; 20.4) |
Total parotid gland | 23.5 ± 4.9 | 31.1 ± 4.8 | 0.000 | 8.0 (3.0; 12.2) |
Ipsilateral submandibular gland | 60.7 ± 3.7 | 62.3 ± 5.6 | 0.088 | 0.2 (−1.1; 9.2) |
Contralateral submandibular gland | 17.8 ± 13.8 | 53.7 ± 2.8 | 0.000 | 41.5 (11.4; 45.0) |
Total submandibular gland | 38.4 ± 7.8 | 57.9 ± 2.0 | 0.000 | 21.7 (5.7; 28.7) |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Haderlein, M.; Speer, S.; Ott, O.; Lettmaier, S.; Hecht, M.; Semrau, S.; Frey, B.; Scherl, C.; Iro, H.; Kesting, M.; et al. Dose Reduction to the Swallowing Apparatus and the Salivary Glands by De-Intensification of Postoperative Radiotherapy in Patients with Head and Neck Cancer: First (Treatment Planning) Results of the Prospective Multicenter DIREKHT Trial. Cancers 2020, 12, 538. https://doi.org/10.3390/cancers12030538
Haderlein M, Speer S, Ott O, Lettmaier S, Hecht M, Semrau S, Frey B, Scherl C, Iro H, Kesting M, et al. Dose Reduction to the Swallowing Apparatus and the Salivary Glands by De-Intensification of Postoperative Radiotherapy in Patients with Head and Neck Cancer: First (Treatment Planning) Results of the Prospective Multicenter DIREKHT Trial. Cancers. 2020; 12(3):538. https://doi.org/10.3390/cancers12030538
Chicago/Turabian StyleHaderlein, Marlen, Stefan Speer, Oliver Ott, Sebastian Lettmaier, Markus Hecht, Sabine Semrau, Benjamin Frey, Claudia Scherl, Heinrich Iro, Marco Kesting, and et al. 2020. "Dose Reduction to the Swallowing Apparatus and the Salivary Glands by De-Intensification of Postoperative Radiotherapy in Patients with Head and Neck Cancer: First (Treatment Planning) Results of the Prospective Multicenter DIREKHT Trial" Cancers 12, no. 3: 538. https://doi.org/10.3390/cancers12030538
APA StyleHaderlein, M., Speer, S., Ott, O., Lettmaier, S., Hecht, M., Semrau, S., Frey, B., Scherl, C., Iro, H., Kesting, M., & Fietkau, R. (2020). Dose Reduction to the Swallowing Apparatus and the Salivary Glands by De-Intensification of Postoperative Radiotherapy in Patients with Head and Neck Cancer: First (Treatment Planning) Results of the Prospective Multicenter DIREKHT Trial. Cancers, 12(3), 538. https://doi.org/10.3390/cancers12030538